Leishmania Major Infection in Major Histocompatibility Complex Class II-Deficient Mice: CD8+ T Cells Do not Mediate a Protective Immune Response

This publication has 28 references indexed in Scilit:

• Response of scid mice to establishment of Leishmania major infection
  Clinical and Experimental Immunology, 1995
• Immune response to Mycobacterium bovis bacille Calmette Guérin infection in major histocompatibility complex class I‐ and II‐deficient knock‐out mice: contribution of CD4 and CD8 T cells to acquired resistance
  European Journal of Immunology, 1995
• Intravenous injection of irradiated Leishmania major into susceptible BALB/c mice: immunization or protective tolerance
  International Immunology, 1994
• CD4+ effector cells default to the Th2 pathway in interferon gamma-deficient mice infected with Leishmania major.
  The Journal of Experimental Medicine, 1994
• Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice.
  The Journal of Experimental Medicine, 1993
• Reconstitution of C.B‐17 scid mice with BALB/c T cells initiates a T helper type‐1 response and renders them capable of healing Leishmania major infection
  European Journal of Immunology, 1993
• Production of tumour necrosis factor during murine cutaneous leishmaniasis
  Parasite Immunology, 1990
• A reliable method for simultaneous demonstration of two antigens using a novel combination of immunogold-silver staining and immunoenzymatic labeling.
  Journal of Histochemistry & Cytochemistry, 1990
• Tumor necrosis factor plays a protective role in experimental murine cutaneous leishmaniasis.
  The Journal of Experimental Medicine, 1989
• Monoclonal antibody to murine gamma interferon inhibits lymphokine-induced antiviral and macrophage tumoricidal activities.
  The Journal of Experimental Medicine, 1984